Accurate diagnosis and treatment of acquired demyelinating syndrome in children in the context of molecular age
10.3760/cma.j.cn431274-20231113-00551
- VernacularTitle:分子时代背景下儿童获得性脱髓鞘综合征的精准诊疗
- Author:
Shujing CHEN
1
;
Na GAN
Author Information
1. 广西中医药大学研究生院，南宁 530200
- Keywords:
Child;
Acquired demyelinating syndrome;
Precision medicine
- From:
Journal of Chinese Physician
2023;25(12):1769-1773
- CountryChina
- Language:Chinese
-
Abstract:
Acquired demyelinating syndromes (ADS) are a complex group of central nervous system immune disorders. In recent years, with the continuous in-depth research on the molecular mechanisms and detection technologies of diseases, molecular diagnosis and biological therapy technologies for these immune dysfunction diseases have developed rapidly, and their diagnosis and prognosis have greatly improved. This article focuses on the different subtypes of ADS and related molecular diagnosis and treatment.
